Dilek Kazanci
Dilek Kazanci has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Sema Turan
3 shared publicationsSuheyla Unver
2 shared publicationsUmit Karadeniz
2 shared publicationsA. Özgök
Anesthesiology and Reanimation Clinic, Türkiye Yüksek Ihtisas Education and Research Hospital, Ankara, Turkey
1 shared publicationA.T. Ulus
Cardiovascular Surgery Clinic, Turkiye Yuksek Ihtisas Education and Research Hospital, Ankara, Turkey
1 shared publicationAtilla Kazanci
1 shared publication
Latest Publications
- 30 July 2012
- Published by Logos Medical Publication (Logos Yayincilik Tic. A.S.) in Journal of Cardio-Vascular-Thoracic Anaesthesia and Intensive Care Society
- Vol. 17 (4) , 99-104
A New Intervention For Preventing Urinary Tract Infections: Uroshield
- 30 July 2012
- Published by Logos Medical Publication (Logos Yayincilik Tic. A.S.) in Journal of Cardio-Vascular-Thoracic Anaesthesia and Intensive Care Society
- Vol. 17 (4) , 99-104
A New Intervention For Preventing Urinary Tract Infections: Uroshield
- 1 July 2012
- Published by Elsevier in Transplantation Proceedings
- Vol. 44 (6) , 1759-1760
Cardiac Arrest that Developed during Liver Transplantation and Intervention with Cardiopulmonary Bypass: Case Report
- 1 July 2012
- Published by Elsevier in Transplantation Proceedings
- Vol. 44 (6) , 1759-1760
Cardiac Arrest that Developed during Liver Transplantation and Intervention with Cardiopulmonary Bypass: Case Report
- 1 January 2010
- Vol. 20 (1) , 43-9
Comparison of the effect of mexiletine and methylprednisolone on neural function and histopathological damage after transient spinal cord ischemia in rabbits.
The purpose of this study was to investigate the effect of mexiletine on the neural function and histopathological changes after ischemic spinal cord injury in rabbits. We also compared the effect of mexiletine to that of methylprednisolone. Twenty six male New Zealand white rabbits were randomly divided into six groups. Group 1; sham operated group (n=3) underwent only the surgical exposure of infrarenal aorta. Group 2 (n=4) received neither intravenous (iv) nor intraperitoneal medication but the infrarenal aorta was cross-clamped. Group 3 (n=5) received intravenous infusion of 20 ml/kg/h normal saline. Group 4 (n=5) received 30 mg/kg intravenous methylprednisolone. Group 5 (n=3) received intraperitoneal 20mg/kg/h normal saline. Group 6 (n=6) received 50mg/kg mexiletine intraperitoneally. Temporary spinal cord ishemia was induced by infrarenal aortic occlusion for 25 minutes and followed by reperfusion. The neural status was scored using the Tarlov criteria at 24 hours after reperfusion. Immediately after the neurological scoring, the spinal cords of all animals were removed for histopathological study. Histopathological examination scores were significantly higher in group 6 compared to group 2 (p < 0.05). Mexiletine can significantly ameloriate the neural function and prevent histopathological damage after transient spinal cord ischemia in rabbits. This is the first research that investigates the neuron=protective effect of mexiletine in a spinal cord ischemia model.
- 1 January 2010
- Vol. 20 (1) , 43-9
Comparison of the effect of mexiletine and methylprednisolone on neural function and histopathological damage after transient spinal cord ischemia in rabbits.
The purpose of this study was to investigate the effect of mexiletine on the neural function and histopathological changes after ischemic spinal cord injury in rabbits. We also compared the effect of mexiletine to that of methylprednisolone. Twenty six male New Zealand white rabbits were randomly divided into six groups. Group 1; sham operated group (n=3) underwent only the surgical exposure of infrarenal aorta. Group 2 (n=4) received neither intravenous (iv) nor intraperitoneal medication but the infrarenal aorta was cross-clamped. Group 3 (n=5) received intravenous infusion of 20 ml/kg/h normal saline. Group 4 (n=5) received 30 mg/kg intravenous methylprednisolone. Group 5 (n=3) received intraperitoneal 20mg/kg/h normal saline. Group 6 (n=6) received 50mg/kg mexiletine intraperitoneally. Temporary spinal cord ishemia was induced by infrarenal aortic occlusion for 25 minutes and followed by reperfusion. The neural status was scored using the Tarlov criteria at 24 hours after reperfusion. Immediately after the neurological scoring, the spinal cords of all animals were removed for histopathological study. Histopathological examination scores were significantly higher in group 6 compared to group 2 (p < 0.05). Mexiletine can significantly ameloriate the neural function and prevent histopathological damage after transient spinal cord ischemia in rabbits. This is the first research that investigates the neuron=protective effect of mexiletine in a spinal cord ischemia model.
- Open Access
- 1 January 2009
- Published by Medknow in Annals of Cardiac Anaesthesia
- Vol. 12 (2) , 107-12
A comparison of the effects of desflurane, sevoflurane and propofol on QT, QTc, and P dispersion on ECG
The aim of this prospective, randomized, and double-blinded study was to compare the effects of desflurane, sevoflurane, propofol on both atrial and ventricular wall function by measurement of QT dispersion (QTd), corrected QT dispersion (QTcd), and P dispersion (Pd) on electrocardiogram (ECG). Forty-six patients from the American Society of Anesthesiologists class I−II undergoing noncardiac surgery, were enrolled in this study. Patients were randomly allocated to receive desflurane, sevoflurane or propofol anesthesia. ECG recordings were taken before and after 5 minutes of drug administration. Induction with desflurane significantly increased the QTd compared to baseline (38 ? 2 ms vs. 62 ? 6 ms, P < 0.05). Sevoflurane and propofol anesthesia was not associated with any changes in QTd. QTcd was increased with desflurane induction and decreased with sevoflurane and propofol induction, but this decrease was only significant in the propofol group (67 ? 5 ms vs. 45 ? 3 ms, P < 0.05). Pd was significantly increased after induction with desflurane (34 ? 3 vs. 63 ? 6 ms, P < 0.05). There was a significant increase in QTd and Pd in desflurane group, but this increment did not cause any dangerous arrhythmias. QTcd significantly decreased in propofol group. We believe that further investigations are required for using desflurane as safe as sevoflurane and propofol in noncardiac surgery patients who have high cardiac arrhythmia and ischemia risk.
- 1 January 2009
- Published by Medknow in Annals of Cardiac Anaesthesia
- Vol. 12 (2) , 107-12
Open AccessA comparison of the effects of desflurane, sevoflurane and propofol on QT, QTc, and P dispersion on ECG
The aim of this prospective, randomized, and double-blinded study was to compare the effects of desflurane, sevoflurane, propofol on both atrial and ventricular wall function by measurement of QT dispersion (QTd), corrected QT dispersion (QTcd), and P dispersion (Pd) on electrocardiogram (ECG). Forty-six patients from the American Society of Anesthesiologists class I−II undergoing noncardiac surgery, were enrolled in this study. Patients were randomly allocated to receive desflurane, sevoflurane or propofol anesthesia. ECG recordings were taken before and after 5 minutes of drug administration. Induction with desflurane significantly increased the QTd compared to baseline (38 ? 2 ms vs. 62 ? 6 ms, P < 0.05). Sevoflurane and propofol anesthesia was not associated with any changes in QTd. QTcd was increased with desflurane induction and decreased with sevoflurane and propofol induction, but this decrease was only significant in the propofol group (67 ? 5 ms vs. 45 ? 3 ms, P < 0.05). Pd was significantly increased after induction with desflurane (34 ? 3 vs. 63 ? 6 ms, P < 0.05). There was a significant increase in QTd and Pd in desflurane group, but this increment did not cause any dangerous arrhythmias. QTcd significantly decreased in propofol group. We believe that further investigations are required for using desflurane as safe as sevoflurane and propofol in noncardiac surgery patients who have high cardiac arrhythmia and ischemia risk.